Literature DB >> 22091326

Solitary giant neurofibroma of the scalp with calvarial defect in a child.

N J Ismail1, B B Shehu, A Lasseini, I Hassan, D J Shilong, J O Obande, S M Sahabi.   

Abstract

Neurofibroma of the scalp are mostly multiple as part of neurofibromatosis or other phakomatosis. De novo solitary types are less common and rarely erode the skull, unlike the intracranial counterpart. Skull erosion has been reported in adults with longstanding plexiform neurofibromas. We report a giant neurofibroma on the scalp of a five-year-old boy, managed in our center. Although this condition is a rare entity, it should be anticipated and the treatment strategy should include repair of the skull defect.

Entities:  

Keywords:  Calvarial defect; scalp neurofibroma; solitary giant

Year:  2010        PMID: 22091326      PMCID: PMC3214485          DOI: 10.4103/2006-8808.63718

Source DB:  PubMed          Journal:  J Surg Tech Case Rep        ISSN: 2006-8808


INTRODUCTION

Neurofibromas are tumors of nerve sheath origin and may arise from Schwann cells, perineural cells[1] or fibroblasts.[2] They present as individual tumors or in syndromic forms with multiple skin nodules, as in neurofibromatosis and other phakomatosis. They have many similarities with schwannomas. The differentiating features include the presence of neurofibromatosis, nerve fibers, and more myxoid tissue (Antoni B tissue) in the neurofibromas, while schwannomas are well capsulated, have a more compact matrix, a fascicular formation, and the presence of Antoni A cells. In the head and scalp, they are more common in the intracranial compartment, or are present as plexiform neurofibromas. Malignant degeneration with skull erosion is more common in intracranial lesions and those with background neurofibromatosis.[2] Giant forms of neurofibromas of the scalp with erosion of the skull have been documented in adults, and most have been in patients with neurofibromatosis or pre-existing plexiform neurofibromas. Such an occurrence is rare in children. We report a case of a five-year-old boy, managed in our center, with a giant frontal neurofibroma with an extensive calvarial defect.

CASE REPORT

A five-year-old boy presented with seven weeks’ history of a progressive and painless swelling on the right side of the forehead and temporal region [Figure 1]. There was no headache, vomiting, visual impairment or seizures. Examination revealed a young boy who was not pale, not febrile, had no lymphadenopathy, and there were no other features of neurofibromatosis or phakomatosis. He had a huge irregular right frontal swelling, which was painless, with no skin discoloration over it; it measured 16 × 12 cm. It was multinodular with cystic and solid components, not tender, but fixed to the underlying skull [Figure 1]. The Glasgow coma score was 15, there were no cranial nerve deficits; the motor and sensory systems were also normal.
Figure 1

Preoperative picture of the patient showing a large right frontal swelling

Preoperative picture of the patient showing a large right frontal swelling Laboratory investigations, which included hemogram, electrolytes, and urea, were all within normal limits. A preoperative brain CT scan showed a huge right frontal extradural, which was enhanced with contrast administration. It had a central cystic component and a large right frontotemporal skull defect [Figure 2].
Figure 2

Preoperative contrast brain CT scan showing a huge extra axial tumor in the right fronto-temporal area, destroying the frontal bone with intra- and extracranial components. There is effacement of the ventricles

Preoperative contrast brain CT scan showing a huge extra axial tumor in the right fronto-temporal area, destroying the frontal bone with intra- and extracranial components. There is effacement of the ventricles The surgical plan was tumor excision and cranioplasty. The finding at the surgery was a huge soft yellowish extradural tumor, with a cystic (necrotic) center. The tumor invaded the frontotemporal bone and extended to the right ethmoidal sinus and the right temporalis muscle. The area of bony defect measured 10 cm in the widest diameter. Most of the tumor was, however, adherent to parts of the frontal bone. The patient had a one-stage bifrontal craniectomy, with complete tumor excision, and frontal cranioplasty with antibiotic impregnated methyl methacrylate [Figure 3]. He required blood transfusion intraoperatively. Postoperative treatment included intravenous ceftriaxone 100 mg/Kg daily, intravenous Phenobarbitone 5 mg/Kg eight hourly, and intramuscular pentazocine 1 mg/Kg eight hourly, for 48 hours. He had an uneventful recovery and was discharged home 11 days after surgery.
Figure 3

Intraoperative image of the patient. After removal of the pathological bone, cranioplasty with molded methyl methacrylate was carried out. The implant was kept in place with a Nylon 1 suture

Intraoperative image of the patient. After removal of the pathological bone, cranioplasty with molded methyl methacrylate was carried out. The implant was kept in place with a Nylon 1 suture The histology report was consistent with neurofibroma [Figure 4]. Brain C T scan at eight weeks post surgery showed no residual tumor [Figure 5]. His neurological status remained normal.
Figure 4

Photomicrograph of the excised tumor, showing neurofibroma composed of proliferating spindle-shaped cells, with dark nuclei, disposed in a loose myxoid background. The cells have wavy to comma-shaped nuclei and moderate cytoplasm. H and E stain, ×400

Figure 5

Postoperative contrast CT at eight weeks. There was reexpansion of the right frontal lobe

Photomicrograph of the excised tumor, showing neurofibroma composed of proliferating spindle-shaped cells, with dark nuclei, disposed in a loose myxoid background. The cells have wavy to comma-shaped nuclei and moderate cytoplasm. H and E stain, ×400 Postoperative contrast CT at eight weeks. There was reexpansion of the right frontal lobe

DISCUSSION

Giant solitary neurofibroma of the scalp without neurofibromatosis is rare. Only three cases have been reported thus far. All were adults, with a slow rate of tumor growth, over decades.[3] To our knowledge no case has been reported in children. The rapidity of growth and site of occurrence were the other peculiarities of this case. Fibrous dysplasia was a differential because of the patient's age and location of the tumor. It was reported that rapid growth could have been because of acute, severe bleeding into the tumor[4] or malignant transformation, but that was not the case in this patient. Most reported cases of giant scalp neurofibroma were in Japanese literature.[3-5] The reason for this was not clear because of the relatively small number of cases reported. Skull defect with sclerotic margins was more suggestive of an underlying neurogenic tumor;[6] this patient had a rather osteolytic bony lesion. Bone defects were more common in neurofibroma associated with neurofibromatosis.[3-5] The patient did not present with any stigmata of neurofibromatosis. The extent of the tumor and involved parts of the brain could be assessed with a contrast CT scan and magnetic resonance imaging. The clinical diagnosis might still be difficult and could only be confirmed by histology. The aim of the surgery was a one-stage complete tumor excision together with the involved bony margins, and cranioplasty, to protect the brain in areas of bone loss. The cosmetic outcome was also important, as the child had reached school age. There may be a need for a second surgery in the future, to put an appropriately sized implant, when the child has reached adulthood. This is because the methyl methacrylate implant has a fixed size and will not adapt with the changing morphology of the child's skull as the brain grows. Other materials that have been used to close the skull defects include split autogenous calvarial bone, rib grafts, and titanium plates. The single stage procedure allowed the patient to undergo only one procedure rather than two or more staged operations and avoided several weeks with a substantial bony defect. One potential problem was the possibility of tumor regrowth in the presence of an implant. This was avoided by obtaining a good margin of resection. Regular follow up with imaging studies was necessary to identify any early recurrence. Solitary giant neurofibroma of the scalp is rare in children. Clinical diagnosis may be difficult, and surgical treatment must be individualized. Regular radiological studies during follow-up visits are necessary to detect early recurrence.
  2 in total

1.  Rapid expansion of benign scalp neurofibroma caused by massive intratumoral hemorrhage--case report.

Authors:  Masanori Tsutsumi; Kiyoshi Kazekawa; Akira Tanaka; Yasushi Ueno; Yasuyuki Nomoto; Kohei Nii; Seiji Haraoka
Journal:  Neurol Med Chir (Tokyo)       Date:  2002-08       Impact factor: 1.742

2.  [Giant neurofibroma of the occipital scalp associated with lambda defect-case report (author's transl)].

Authors:  S Nakasu; Y Nakasu; I Matsuda; J Handa
Journal:  No To Shinkei       Date:  1981-02
  2 in total
  5 in total

1.  Rapidly growing diffuse neurofibroma of the scalp with calvarial defect in a young woman: A rare entity.

Authors:  Lokesh Suresh Nehete; Raghavendra Sharma; Prashant Raj Singh; Surendra Gupta
Journal:  Surg Neurol Int       Date:  2020-10-02

2.  Split calvarial bone graft for the reconstruction of skull defects.

Authors:  Amit Agrawal; Lakshmi N Garg
Journal:  J Surg Tech Case Rep       Date:  2011-01

3.  Solitary giant diffuse neurofibroma of the scalp with calvarial defect.

Authors:  Sanjeev Kumar; Pramod Chaurasia; Daljit Singh; Vineeta V Batra; Rajendra Aher
Journal:  Asian J Neurosurg       Date:  2017 Apr-Jun

4.  Scalp Plexiform Neurofibrosarcoma With Intrathoracic Fibrosarcoma: A Case Report.

Authors:  Titus O Chukwuanukwu; Alvan-Emeka K Ukachukwu; Kenneth C Etukokwu; Evaristus E Afiadigwe; Akunne I Apakama; Arthur E Anyabolu; Michael E Onwukamuche
Journal:  Cureus       Date:  2022-08-10

5.  Solitary giant neurofibroma of thigh.

Authors:  Mohammad Ali Tahririan; Ali Hekmatnia; Hossein Ahrar; Mitra Heidarpour; Farzaneh Hekmatnia
Journal:  Adv Biomed Res       Date:  2014-07-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.